Ampoules with the vaccine «Gam-Covid-Vac» («Sputnik V») MOSCOW, 13 Jan. The Russian Direct Investment Fund (RDIF) next week will publish important data on the effectiveness of the Russian Sputnik vaccine against the omicron strain, said the head of the fund, Kirill Dmitriev, speaking at the Gaidar Forum. “The Russian vaccine is best against omicron. and we will announce important data in this regard next week, «he said. According to Dmitriev, Western media often impede the dissemination of information about the Russian vaccine. “We believe that this is extremely unethical, because we are talking about the lives of people, and people in the world should know the truth. And the truth is that Sputnik protects well from hospitalization and deaths from omicron, better than other vaccines, «he stressed. The head of the RDIF drew attention to the tough competition of pharmaceutical companies that exists in the global market for vaccines against coronavirus. Competitors from «big pharma», according to him, use all methods available to them in this fight. RIA Novosti acts as an information partner of the Gaidar Forum.
Virologist told how long the omicron wave will last in Russia

